Skandinaviska Enskilda Banken AB (publ) - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 220 filers reported holding SAGE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$559,000
-87.7%
12,608
-84.2%
0.00%
-89.3%
Q2 2021$4,528,000
-0.8%
79,708
+30.7%
0.03%
-6.7%
Q1 2021$4,566,000
+2408.8%
61,008
+2805.1%
0.03%
+2900.0%
Q4 2020$182,000
-33.6%
2,100
-68.2%
0.00%
-50.0%
Q2 2020$274,0006,6000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders